|
"ann lii cheng"的相关文件
显示项目 641-665 / 690 (共28页)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T06:55:45Z |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC;Lu, YS;Shun, CT;Yao, YT;Chang, WC;Cheng, AL; Lien, H.-C. and Lu, Y.-S. and Shun, C.-T. and Yao, Y.-T. and Chang, W.-C. and Cheng, A.-L.; Lien, HC; CHIA-TUNG SHUN; HUANG-CHUN LIEN; Lu, YS; ANN-LII CHENG; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 臺大學術典藏 |
2018-09-10T06:53:03Z |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol
|
Cheng, A.-L. and Yeh, K.-H. and Uen, W.-C. and Hung, R.-L. and Liu, M.-Y. and Wang, C.-H.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:53:00Z |
Comprehensive Locoregional Treatment and Systemic Therapy for Postmastectomy Isolated Locoregional Recurrence
|
Sung-Hsin Kuo and Chiun-Sheng Huang and Wun-Hon Kuo and Ann-Lii Cheng and King-Jeng Chang and Jason Chia-Hsien Cheng; CHIUN-SHENG HUANG; Sung-Hsin Kuo; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:52:59Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
|
Chiun Hsu and Sung-Hsin Kuo and Fu-Chang Hu and Ann-Lii Cheng and Jin-Yuan Shih and Chong-Jen Yu and Chia-Chi Lin and Tsu-Chen Huang and Pan-Chyr Yang and Chih-Hsin Yang; Chong-Jen Yu; Sung-Hsin Kuo; JIN-YUAN SHIH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:52:55Z |
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells
|
Lin, H.-J.L.;Zuo, T.;Lin, C.-H.;Chieh, T.K.;Liyanarachchi, S.;Sun, S.;Shen, R.;Deatherage, D.E.;Potter, D.;Asamoto, L.;Lin, S.;Yan, P.S.;Cheng, A.-L.;Ostrowski, M.C.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:51:18Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
JIN-YUAN SHIH; CHIA-TUNG SHUN; ANN-LII CHENG; Yang, C.-H. and Yu, C.-J. and Shih, J.-Y. and Chang, Y.-C. and Hu, F.-C. and Tsai, M.-C. and Chen, K.-Y. and Lin, Z.-Z. and Huang, C.-J. and Shun, C.-T. and Huang, C.-L. and Bean, J. and Cheng, A.-L. and Pao, W. and Yang, P.-C.; YEUN-CHUNG CHANG; Chong-Jen Yu; PAN-CHYR YANG |
| 臺大學術典藏 |
2018-09-10T06:48:03Z |
Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers
|
Yeh, K.-H. and Chen, C.-L. and Shun, C.-T. and Lin, J.-T. and Lee, W.-J. and Lee, P.-H. and Chen, Y.-C. and Cheng, A.-L.; PO-HUANG LEE; KUN-HUEI YEH; CHIA-TUNG SHUN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:48:02Z |
High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy
|
PO-HUANG LEE; KUN-HUEI YEH; CHIA-TUNG SHUN; ANN-LII CHENG; Yeh, K.-H. and Shun, C.-T. and Chen, C.-L. and Lin, J.-T. and Lee, W.-J. and Lee, P.-H. and Chen, Y.-C. and Cheng, A.-L. |
| 臺大學術典藏 |
2018-09-10T06:29:34Z |
Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells
|
Chia, H.C.;Chen, P.-J.;Lee, P.-H.;Cheng, A.-L.;Hsu, H.-C.;Cheng, J.C.-H.Chou, Ch (Chou, Chia Hung); Chen, Pj (Chen, Pei-Jer); Lee, Ph (Lee, Po-Huang); Cheng, Al (Cheng, Ann-Lii); Hsu, Hc (Hsu, Hui-Chen); Cheng, Ach (Cheng; Chou, CH (Chou, Chia Hung); Chen, PJ (Chen, Pei-Jer); Lee, PH (Lee, Po-Huang); Cheng, AL (Cheng, Ann-Lii); Hsu, HC (Hsu, Hui-Chen); Cheng, ACH (Cheng; Chou, CH (Chou, Chia Hung); PO-HUANG LEE; PEI-JER CHEN; Chen, PJ (Chen, Pei-Jer); Lee, PH (Lee, Po-Huang); ANN-LII CHENG; Cheng, AL (Cheng, Ann-Lii); Hsu, HC (Hsu, Hui-Chen); Cheng, ACH (Cheng |
| 臺大學術典藏 |
2018-09-10T06:22:13Z |
Stability of curcumin in buffer solutions and characterization of its degradation products
|
Wang, Y.-J.;Pan, M.-H.;Cheng, A.-L.;Lin, L.-I.;Ho, Y.-S.;Hsieh, C.-Y.;Lin, J.-K; Wang, Y.-J.; Pan, M.-H.; Cheng, A.-L.; Lin, L.-I.; Ho, Y.-S.; Hsieh, C.-Y.; Lin, J.-K; LIANG-IN LIN; ANN-LII CHENG; MIN-HSIUNG PAN |
| 臺大學術典藏 |
2018-09-10T06:15:10Z |
Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability
|
Wu, M.-S. and Sheu, J.-C. and Shun, C.-T. and Lee, W.-J. and Wang, J.-T. and Wang, T.-H. and Cheng, A.-L. and Lin, J.-T.; JIN-CHUAN SHEU; MING-SHIANG WU; CHIA-TUNG SHUN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T06:13:57Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
ANN-LII CHENG; JANG-MING LEE; KUN-HUEI YEH; CHIH-HUNG HSU; Lin, C.-C. and Hsu, C.-H. and Cheng, J.C. and Wang, H.-P. and Lee, J.-M. and Yeh, K.-H. and Yang, C.-H. and Lin, J.-T. and Cheng, A.-L. and Lee, Y.-C. |
| 臺大學術典藏 |
2018-09-10T06:13:47Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin, Chia-Chi;Chih-Hung;Hsu;Huang, Chao-Yuan;Keng, Hsiao-Yi;Tsai, Yu-Chieh;Huang, Kuo-How;Cheng, Ann-Lii;Pu, Yeong-Shiau; Lin, C.-C. and Hsu, C.-H. and Huang, C.-Y. and Keng, H.-Y. and Tsai, Y.-C. and Huang, K.-H. and Cheng, A.-L. and Pu, Y.-S.; Lin, Chia-Chi; CHAO-YUAN HUANG; CHIH-HUNG HSU; Chih-Hung; Hsu; KUO-HOW HUANG; YU-CHIEH TSAI; Huang, Chao-Yuan; ANN-LII CHENG; Keng, Hsiao-Yi; Tsai, Yu-Chieh; YEONG-SHIAU PU; Huang, Kuo-How; Cheng, Ann-Lii; Pu, Yeong-Shiau |
| 臺大學術典藏 |
2018-09-10T05:58:54Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien, H.-C.; Lu, Y.-S.; Cheng, A.-L.; Chang, W.-C.; Jeng, Y.-M.; Kuo, Y.-H.; Huang, C.-S.; Chang, K.-J.; Yao, Y.-T.; CHIUN-SHENG HUANG; YUNG-MING JENG; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:49:42Z |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Lu, Y.-S.;Yeh, P.-Y.;Chuang, S.-E.;Gao, M.;Kuo, M.-L.;Cheng, A.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:49:06Z |
Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma
|
Cheng, A.-L.;Chen, Y.-C.;Yeh, K.-H.;Chuang, S.-E.;Chen, B.-R.;Chen, D.-S.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:49:05Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao, Y.;Li, C.P.;Chao, T.Y.;Su, W.C.;Hsieh, R.K.;Wu, M.F.;Yeh, K.H.;Kao, W.Y.;Chen, L.T.;Cheng, A.L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:46:53Z |
Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma
|
Cheng, T.-Y. and Lin, J.-T. and Chen, L.-T. and Shun, C.-T. and Wang, H.-P. and Lin, M.-T. and Wang, T.-E. and Cheng, A.-L. and Wu, M.-S.; TSU-YAO CHENG; MING-SHIANG WU; CHIA-TUNG SHUN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:45:28Z |
Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin
|
Lin, C.-H. and Kuo, K.-T. and Chuang, S.-S. and Kuo, S.-H. and Chang, J.H. and Chang, K.-C. and Hsu, H.-C. and Tien, H.-F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:30:33Z |
Clinicopathologic characteristics of helicobacter pyloric seropositive gastric adenocarcinomas
|
Lee, W.-J.;Lin, J.-T.;Lee, W.C.;Shun, C.-T.;Hong, R.-L.;Cheng, A.-L.;Lee, P.-H.;Wei, T.-C.;Chen, K.-M.Lee, Wei-Jei; Lee, Po-Hung; Wei, Ta-Cheng; Chen, Kai-Mo; Lin, Jaw-Town; Shun, Chia-Tung; Hong, Ruey-Long; Cheng, Ann-Lii; Lee, Wen Chung; Lee, Wei-Jei; Lee, Po-Hung; Wei, Ta-Cheng; Chen, Kai-Mo; Lin, Jaw-Town; Shun, Chia-Tung; Hong, Ruey-Long; Cheng, Ann-Lii; Lee, Wen Chung; Lee, Wei-Jei; PO-HUANG LEE; WEN-CHUNG LEE; Lee, Po-Hung; ANN-LII CHENG; Wei, Ta-Cheng; Chen, Kai-Mo; Lin, Jaw-Town; Shun, Chia-Tung; Hong, Ruey-Long; Cheng, Ann-Lii; Lee, Wen Chung |
| 臺大學術典藏 |
2018-09-10T05:19:58Z |
Effect of thalidomide in hepatocellular carcinoma: Assessment with power Doppler US and analysis of circulating angiogenic factors
|
Hsu, C.;Chen, C.-N.;Chen, L.-T.;Wu, C.-Y.;Hsieh, F.-J.;Cheng, A.-L.; CHIUNG-NIEN CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:14:41Z |
Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung
|
Yeh, K.-H.;Yeh, S.-H.;Wan, J.-P.;Shen, Y.-C.;Cheng, A.-L.; KUN-HUEI YEH; ANN-LII CHENG; SHIOU-HWEI YEH |
| 臺大學術典藏 |
2018-09-10T05:14:41Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Yeh, K.H.;Lu, Y.S.;Hsu, C.H.;Lin, J.F.;Chao, H.J.;Huang, T.C.;Chung, C.Y.;Chang, C.S.;Yang, C.H.;Cheng, A.L.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T05:14:39Z |
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )
|
Yeh, K.-H. and Kuo, S.-H. and Chen, L.-T. and Mao, T.-L. and Doong, S.-L. and Wu, M.-S. and Hsu, H.-C. and Tzeng, Y.-S. and Chen, C.-L. and Lin, J.-T. and Cheng, A.-L.; Sung-Hsin Kuo; KUN-HUEI YEH; MING-SHIANG WU; SHIN-LIAN DOONG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T04:46:19Z |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh, P.Y.;Chuang, S.-E.;Yeh, K.-H.;Song, Y.C.;Chang, L.L.-Y.;Cheng, A.-L.Yeh, Py;Chuang, Se;Kun-Huei, Yeh;Song, Yc;Chang, Ll;Cheng, Al.; KUN-HUEI YEH; Yeh, PY; Chuang, SE; ANN-LII CHENG; Kun-Huei, Yeh; Song, YC; Chang, LL; Cheng, AL. |
显示项目 641-665 / 690 (共28页)
<< < 19 20 21 22 23 24 25 26 27 28 > >>
每页显示[10|25|50]项目
|
